209 related articles for article (PubMed ID: 15561910)
1. Gastric inhibitory polypeptide and glucagon-like peptide-1 in the pathogenesis of type 2 diabetes.
Nauck MA; Baller B; Meier JJ
Diabetes; 2004 Dec; 53 Suppl 3():S190-6. PubMed ID: 15561910
[TBL] [Abstract][Full Text] [Related]
2. The importance of glucose-dependent insulinotropic polypeptide receptor activation for the effects of tirzepatide.
Gasbjerg LS; Rosenkilde MM; Meier JJ; Holst JJ; Knop FK
Diabetes Obes Metab; 2023 Nov; 25(11):3079-3092. PubMed ID: 37551549
[TBL] [Abstract][Full Text] [Related]
3. Secretion of glucagon, GLP-1 and GIP may be affected by circadian rhythm in healthy males.
Zilstorff DB; Richter MM; Hannibal J; Jørgensen HL; Sennels HP; Wewer Albrechtsen NJ
BMC Endocr Disord; 2024 Mar; 24(1):38. PubMed ID: 38481208
[TBL] [Abstract][Full Text] [Related]
4. Incretin hormone responses to carbohydrate and protein/fat are preserved in adults with sulfonylurea-treated KCNJ11 neonatal diabetes.
Bowman P; Patel KA; McDonald TJ; Holst JJ; Hartmann B; Leveridge M; Shields BM; Hammersley S; Spaull SR; Knight BA; Flanagan SE; Shepherd MH; Andrews RC; Hattersley AT
J Diabetes Investig; 2023 Dec; 14(12):1378-1382. PubMed ID: 37602910
[TBL] [Abstract][Full Text] [Related]
5. An extended minimal model of OGTT: estimation of α- and β-cell dysfunction, insulin resistance, and the incretin effect.
Subramanian V; Bagger JI; Harihar V; Holst JJ; Knop FK; Villsbøll T
Am J Physiol Endocrinol Metab; 2024 Feb; 326(2):E182-E205. PubMed ID: 38088864
[TBL] [Abstract][Full Text] [Related]
6. Influence of gastric inhibitory polypeptide on pentagastrin-stimulated gastric acid secretion in patients with type 2 diabetes and healthy controls.
Meier JJ; Nauck MA; Kask B; Holst JJ; Deacon CF; Schmidt WE; Gallwitz B
World J Gastroenterol; 2006 Mar; 12(12):1874-80. PubMed ID: 16609993
[TBL] [Abstract][Full Text] [Related]
7. Impact of Incretin Hormone Receptors on Insulin-Independent Glucose Disposal in Model Experiments in Mice.
Ovlund T; Pacini G; Ahrén B
Front Endocrinol (Lausanne); 2021; 12():680153. PubMed ID: 34168617
[TBL] [Abstract][Full Text] [Related]
8. Impact on Glucose Homeostasis: Is Food Biofortified with Molybdenum a Workable Solution? A Two-Arm Study.
Vasto S; Di Gaudio F; Raso M; Sabatino L; Caldarella R; De Pasquale C; Di Rosa L; Baldassano S
Nutrients; 2022 Mar; 14(7):. PubMed ID: 35405964
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor.
Parthier C; Kleinschmidt M; Neumann P; Rudolph R; Manhart S; Schlenzig D; Fanghänel J; Rahfeld JU; Demuth HU; Stubbs MT
Proc Natl Acad Sci U S A; 2007 Aug; 104(35):13942-7. PubMed ID: 17715056
[TBL] [Abstract][Full Text] [Related]
10. Glucose effectiveness: Lessons from studies on insulin-independent glucose clearance in mice.
Ahrén B; Pacini G
J Diabetes Investig; 2021 May; 12(5):675-685. PubMed ID: 33098240
[TBL] [Abstract][Full Text] [Related]
11. The incretin concept today.
Creutzfeldt W
Diabetologia; 1979 Feb; 16(2):75-85. PubMed ID: 32119
[TBL] [Abstract][Full Text] [Related]
12. [Focus on obesity drug treatments].
Favre L
Rev Med Suisse; 2024 Mar; 20(866):570-574. PubMed ID: 38506456
[TBL] [Abstract][Full Text] [Related]
13. Cellular mechanisms of incretin hormone secretion.
Santos-Hernández M; Reimann F; Gribble FM
J Mol Endocrinol; 2024 May; 72(4):. PubMed ID: 38240302
[TBL] [Abstract][Full Text] [Related]
14. Rikkunshito increases peripheral incretin-hormone levels in humans and rats.
Kono H; Furuya S; Akaike H; Shoda K; Kawaguchi Y; Amemiya H; Kawaida H; Ichikawa D
World J Methodol; 2024 Mar; 14(1):88518. PubMed ID: 38577198
[TBL] [Abstract][Full Text] [Related]
15. Glucagon as the First Incretin: Objects (in the Rearview Mirror) Are Closer Than They Appear.
D'Alessio DA; Marks V
Diabetes; 2023 Dec; 72(12):1739-1740. PubMed ID: 37983526
[No Abstract] [Full Text] [Related]
16. The Role of GLP-1, GIP, MCP-1 and IGFBP-7 Biomarkers in the Development of Metabolic Disorders: A Review and Predictive Analysis in the Context of Diabetes and Obesity.
Jędrysik M; Wyszomirski K; Różańska-Walędziak A; Grosicka-Maciąg E; Walędziak M; Chełstowska B
Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255264
[TBL] [Abstract][Full Text] [Related]
17. Useful biomarkers and clinical characteristics of post-pancreatitis diabetes mellitus (PPDM).
Kitamura T
J Clin Endocrinol Metab; 2024 Mar; ():. PubMed ID: 38501454
[No Abstract] [Full Text] [Related]
18. Glucose-dependent insulinotropic polypeptide (Gastric Inhibitory Polypeptide; GIP).
McIntosh CH; Widenmaier S; Kim SJ
Vitam Horm; 2009; 80():409-71. PubMed ID: 19251046
[TBL] [Abstract][Full Text] [Related]
19. Overview of incretin hormones.
Efendic S; Portwood N
Horm Metab Res; 2004; 36(11-12):742-6. PubMed ID: 15655702
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
